Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Gerasimos Filippatos »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Gerasimos Aravantinos < Gerasimos Filippatos < Gerasimos S. Filippatos  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000154 (2017) Milton Packer [États-Unis] ; Richard Holcomb [États-Unis] ; William T. Abraham [États-Unis] ; Stefan Anker [Allemagne] ; Kenneth Dickstein [Norvège] ; Gerasimos Filippatos [Grèce] ; Henry Krum [Australie] ; Aldo P. Maggioni [Italie] ; John J V. Mcmurray [Royaume-Uni] ; Alexandre Mebazaa [France] ; Christopher O'Connor [États-Unis] ; Frank Peacock [États-Unis] ; Piotr Ponikowski [Pologne] ; Frank Ruschitzka [Suisse] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Johannes Holzmeister [Suisse]Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure.
000289 (2017) Giovanni Targher [Italie] ; Marco Dauriz [Italie] ; Cécile Laroche [France] ; Pier Luigi Temporelli [Italie] ; Mahmoud Hassanein [Égypte] ; Petar M. Seferovic [Serbie] ; Jaroslaw Drozdz [Pologne] ; Roberto Ferrari [Italie] ; Stephan Anker [Allemagne] ; Andrew Coats [Royaume-Uni] ; Gerasimos Filippatos [Espagne] ; Maria G. Crespo-Leiro [Espagne] ; Alexandre Mebazaa [France] ; Massimo F. Piepoli [Italie] ; Aldo Pietro Maggioni [France] ; Luigi Tavazzi [Italie]In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry.
000399 (2017) Ovidiu Chioncel [Roumanie] ; Mitja Lainscak [Slovénie] ; Petar M. Seferovic [Serbie] ; Stefan D. Anker [Allemagne] ; Maria G. Crespo-Leiro [Espagne] ; Veli-Pekka Harjola [Finlande] ; John Parissis [Grèce] ; Cecile Laroche [France] ; Massimo Francesco Piepoli [Italie] ; Candida Fonseca [Portugal] ; Alexandre Mebazaa [France] ; Lars Lund [Suède] ; Giuseppe A. Ambrosio [Italie] ; Andrew J. Coats [Royaume-Uni] ; Roberto Ferrari [Italie] ; Frank Ruschitzka [Suisse] ; Aldo P. Maggioni [Italie] ; Gerasimos Filippatos [Grèce]Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
000464 (2017) Ovidiu Chioncel [Roumanie] ; Alexandre Mebazaa [France] ; Veli-Pekka Harjola [Finlande] ; Andrew J. Coats [Royaume-Uni] ; Massimo Francesco Piepoli [Italie] ; Maria G. Crespo-Leiro [Espagne] ; Cecile Laroche [France] ; Petar M. Seferovic [Serbie] ; Stefan D. Anker [Allemagne] ; Roberto Ferrari [Italie] ; Frank Ruschitzka [Suisse] ; Silvia Lopez-Fernandez [Espagne] ; Daniela Miani [Italie] ; Gerasimos Filippatos [Grèce] ; Aldo P. Maggioni [Italie]Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry.
000521 (2017) Marco Dauriz [Italie] ; Giovanni Targher [Italie] ; Cécile Laroche [France] ; Pier Luigi Temporelli [Italie] ; Roberto Ferrari [Italie] ; Stephan Anker [Allemagne] ; Andrew Coats [Australie] ; Gerasimos Filippatos [Espagne] ; Maria Crespo-Leiro [Espagne] ; Alexandre Mebazaa [France] ; Massimo F. Piepoli [Italie] ; Aldo P. Maggioni ; Luigi Tavazzi [Italie]Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry.
000908 (2016) Maria G. Crespo-Leiro [Espagne] ; Stefan D. Anker [Allemagne] ; Aldo P. Maggioni [France] ; Andrew J. Coats [Royaume-Uni] ; Gerasimos Filippatos [Grèce] ; Frank Ruschitzka [Suisse] ; Roberto Ferrari [Italie] ; Massimo Francesco Piepoli [Italie] ; Juan F. Delgado Jimenez [Espagne] ; Marco Metra [Italie] ; Candida Fonseca [Portugal] ; Jaromir Hradec [République tchèque] ; Offer Amir [Israël] ; Damien Logeart [France] ; Ulf Dahlström [Suède] ; Bela Merkely [Hongrie] ; Jaroslaw Drozdz [Pologne] ; Eva Goncalvesova [Slovaquie] ; Mahmoud Hassanein [Égypte] ; Ovidiu Chioncel [Roumanie] ; Mitja Lainscak [Slovénie] ; Petar M. Seferovic ; Dimitris Tousoulis [Grèce] ; Ausra Kavoliuniene [Lituanie] ; Friedrich Fruhwald [Autriche] ; Emir Fazlibegovic [Bosnie-Herzégovine] ; Ahmet Temizhan [Turquie] ; Plamen Gatzov [Bulgarie] ; Andrejs Erglis [Lettonie] ; Cécile Laroche [France] ; Alexandre Mebazaa [France]European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.
000961 (2016) Alexander R. Lyon [Royaume-Uni] ; Eduardo Bossone [Italie] ; Birke Schneider [Allemagne] ; Udo Sechtem [Allemagne] ; Rodolfo Citro [Italie] ; S Richard Underwood [Royaume-Uni] ; Mary N. Sheppard [Royaume-Uni] ; Gemma A. Figtree [Australie] ; Guido Parodi [Italie] ; Yoshihiro J. Akashi [Japon] ; Frank Ruschitzka [Suisse] ; Gerasimos Filippatos [Grèce] ; Alexandre Mebazaa [France] ; Elmir Omerovic [Suède]Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology.
000A07 (2016) Barak Zafrir [Israël] ; Nabeeh Salman [Israël] ; Maria G. Crespo-Leiro [Espagne] ; Stefan D. Anker [Allemagne] ; Andrew J. Coats [Royaume-Uni] ; Roberto Ferrari [Italie] ; Gerasimos Filippatos [Grèce] ; Aldo P. Maggioni [France] ; Alexandre Mebazaa [France] ; Massimo Francesco Piepoli [Italie] ; Frank Ruschitzka [Suisse] ; Maria J. Paniagua-Martin [Espagne] ; Javier Segovia [Espagne] ; Cecile Laroche [France] ; Offer Amir [Israël]Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
000A55 (2016) Gerasimos Filippatos [Grèce] ; Stefan D. Anker [Allemagne] ; Michael Böhm [Allemagne] ; Mihai Gheorghiade [États-Unis] ; Lars K Ber [Danemark] ; Henry Krum [Australie] ; Aldo P. Maggioni [Italie] ; Piotr Ponikowski [Pologne] ; Adriaan A. Voors [Pays-Bas] ; Faiez Zannad [France] ; So-Young Kim [Allemagne] ; Christina Nowack [Allemagne] ; Giovanni Palombo [Royaume-Uni] ; Peter Kolkhof [Allemagne] ; Nina Kimmeskamp-Kirschbaum [Allemagne] ; Alexander Pieper [Allemagne] ; Bertram Pitt [États-Unis]A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
000E36 (2015) Stefan D. Anker [Allemagne] ; Andrew J. S. Coats [Australie, Royaume-Uni] ; Gabriel Cristian [Roumanie] ; Dinu Dragomir [Roumanie] ; Enrico Pusineri [Italie] ; Massimo Piredda [Italie] ; Luca Bettari [Italie] ; Robert Dowling [États-Unis] ; Maurizio Volterrani [Italie] ; Bridget-Anne Kirwan [Suisse] ; Gerasimos Filippatos [Grèce] ; Jean-Louis Mas [France] ; Nicolas Danchin [France] ; Scott D. Solomon [États-Unis] ; Randall J. Lee [États-Unis] ; Frank Ahmann [États-Unis] ; Andy Hinson [États-Unis] ; Hani N. Sabbah [États-Unis] ; Douglas L. Mann [États-Unis]A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)
001268 (2013) Bertram Pitt [États-Unis] ; Lars Kober [Danemark] ; Piotr Ponikowski [Pologne] ; Mihai Gheorghiade [États-Unis] ; Gerasimos Filippatos [Grèce] ; Henry Krum [Australie] ; Christina Nowack [Allemagne] ; Peter Kolkhof [Allemagne] ; So-Young Kim [Allemagne] ; Faiez Zannad [France]Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
001673 (2012) Bertram Pitt [États-Unis] ; Gerasimos Filippatos [Grèce] ; Mihai Gheorghiade [États-Unis] ; Lars Kober [Danemark] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Christina Nowack [Allemagne] ; Peter Kolkhof [Allemagne] ; So-Young Kim [Allemagne] ; Faiez Zannad [France]Rationale and design of ARTS: a randomized, double‐blind study of BAY 94‐8862 in patients with chronic heart failure and mild or moderate chronic kidney disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
6Humans
5Female
5Male
5Middle Aged
4Aged
4Cause of Death
4Registries
3Aged, 80 and over
3Chronic Disease
3Heart Failure (epidemiology)
3Mortality
3Prognosis
3Proportional Hazards Models
3Prospective Studies
3Societies, Medical
2Acute Disease
2Cardiology
2Cardiovascular Diseases (mortality)
2Cohort Studies
2Comorbidity
2Europe (epidemiology)
2Follow-Up Studies
2Heart Failure (physiopathology)
2Hospitalization
2Risk Factors
1Acetylsalicylic acid
1Aldosterone
1Aldosterone antagonist
1Aldosterone antagonist therapy
1Aldosterone antagonists
1Aldosterone blockers
1Alginates (administration & dosage)
1Ambulatory Care
1Angiotensin receptor blocker
1Antagonist
1Available mras
1Available steroidal mras
1Bayer
1Bayer healthcare
1Bayer healthcare pharmaceuticals
1Bayer pharma
1Biomarkers
1Blocker
1Blood pressure
1Blood samples
1Body Surface Area
1Cardiac
1Cardiac function
1Cardiac intervention
1Cardiology (methods)
1Cardiology (organization & administration)
1Cardiovascular
1Cardiovascular Diseases (complications)
1Cardiovascular Diseases (physiopathology)
1Cardiovascular mortality
1Chronic heart failure
1Chronic kidney disease
1Clinical trial
1Concomitant diabetes mellitus
1Concomitant medications
1Consulting fees
1Conventional therapy
1Deleterious changes
1Demographic data
1Diabetes Complications (mortality)
1Diabetes Complications (physiopathology)
1Diabetes Mellitus (epidemiology)
1Disease Management
1Dose groups
1Echocardiography
1Egfr
1Eligible patients
1Eplerenone
1Europe
1Exercise Test
1Exercise Tolerance (physiology)
1Full analysis
1Gerasimos filippatos
1Glucuronic Acid (administration & dosage)
1Glycated haemoglobin
1Healthcare
1Healthcare resource
1Heart Failure (blood)
1Heart Failure (complications)
1Heart Failure (mortality)
1Heart Failure (therapy)
1Heart failure
1Heart rate
1Henry krum
1Hexuronic Acids (administration & dosage)
1Hfref
1Hospital Mortality
1Hospitalization (statistics & numerical data)
1Hydrogel (administration & dosage)
1Hyperglycemia (epidemiology)
1Hyperkalaemia
1Hypertension
1Independent experiments
1Inhibitor
1Lars kober

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Gerasimos Filippatos" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Gerasimos Filippatos" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Gerasimos Filippatos
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024